Bone tissue engineering by ex vivo stem cells ongrowth into three-dimensional trabecular metal
Adult autologous stem cells cultured on a porous, three-dimensional tissue scaffold-implant for bone regeneration by the use of a hyaluronan and/or dexamethasone to accelerate bone healing alone or in combination with recombinant growth factors or transfected osteogenic genes. The scaffold-implant may be machined into a custom-shaped three-dimensional cell culture system for support of cell growth, reservoir for peptides, recombinant growth factors, cytokines and antineoplastic drugs in the presence of a hyaluronan and/or dexamethasone alone or in combination with growth factors or transfected osteogenic genes, to be assembled ex vivo in a tissue incubator for implantation into bone tissue.
1. A three-dimensional tissue scaffold implant for implantation in a patient, comprising:
a shaped, porous three-dimensional metallic tissue scaffold effective to receive tissue ingrowth upon implantation in a patient;
an inert biocompatible metal film present on the surfaces of the porous metallic tissue scaffold; and
ex-vivo applied, living cells in pores of the porous three-dimensional tissue scaffold.
2. The three-dimensional tissue scaffold implant of claim 1 , wherein said porous three-dimensional metallic tissue scaffold is shaped and sized as an acetabular cup implant.
3. The three-dimensional tissue scaffold implant of claim 1 , wherein said inert biocompatible metal film is a chemical vapor deposited metal film.
4. The three-dimensional tissue scaffold implant of claim 1 , wherein said living cells comprise mesenchymal stem cells.
5. The three-dimensional tissue scaffold implant of claim 1 , wherein said porous three-dimensional metallic tissue scaffold has an interconnected porosity for facilitating nutrient diffusion and media circulation throughout the porous three-dimensional metallic tissue scaffold.
6. The three-dimensional tissue scaffold implant of claim 1 further comprising at least one substance selected from the group consisting of a hyaluronan, dexamethasone, protein, peptide, transcript factor, cytokine, therapeutic agent, chitosan, polymer, osteogenic gene and growth factor present on the inert biocompatible metal film.
7. The three-dimensional tissue scaffold implant of claim 1 further comprising at least one substance having been applied ex-vivo with said living cells, said at least one substance selected from the group consisting of a hyaluronan, dexamethasone, protein, peptide, transcription factor, cytokine, therapeutic agent, chitosan, polymer, osteogenic gene and growth factor.
8. A three-dimensional tissue scaffold implant for implantation in a patient, comprising:
a shaped, porous three-dimensional metallic tissue scaffold fabricated as a single implant piece and effective to receive tissue ingrowth upon implantation in a patient, said porous three-dimensional metallic tissue scaffold having an interconnected porosity for facilitating nutrient diffusion and media circulation throughout the porous three-dimensional metallic tissue scaffold;
an inert biocompatible metal film present of the surfaces of the porous metallic tissue scaffold; and
ex-vivo cultured tissue on the porous three-dimensional metallic tissue scaffold.
9. The three-dimensional tissue scaffold implant of claim 8 , wherein said inert biocompatible metal film is a chemical vapor deposited metal film.
10. A method of generating tissue, comprising:
providing a shaped, porous three-dimensional metallic tissue scaffold having an inert biocompatible metal film present on the surfaces of the porous metallic tissue scaffold and having living cells in pores of the porous three-dimensional metallic tissue scaffold, said porous three-dimensional metallic tissue scaffold shaped having an interconnected porosity for facilitating nutrients diffusion and media circulation throughout the porous three-dimensional metallic tissue scaffold; and
placing said porous three-dimensional tissue scaffold in an ex-vivo bioreactor for generating tissue on said porous three-dimensional tissue scaffold.
11. The method of claim 10 , wherein said porous three-dimensional metallic tissue scaffold is shaped and sized as an acetabular cup implant.
12. The method of claim 10 , wherein said porous three-dimensional metallic tissue scaffold has a volume porosity of 75% to 80%.
13. The method of claim 10 , wherein said porous three-dimensional metallic tissue scaffold is disc-shaped.
14. The method of claim 10 , wherein said living cells comprise mesenchymal stem cells.
15. The method of claim 10 , wherein at least one substance selected from the group consisting of a hyaluronan, dexamethasone, protein, peptide, transcript factor, cytokine, therapeutic agent, chitosan, polymer, osteogenic gene and growth factor is further present on the inert biocompatible metal film.
16. The method of claim 10 , wherein at least one substance selected from the group consisting of a hyaluronan, dexamethasone, protein, peptide, transcript factor, cytokine, therapeutic agent, chitosan, polymer, osteogenic gene and growth factor.
17. A method of implantation, comprising:
providing a porous three-dimensional metallic tissue scaffold-implant having an inert biocompatible metal film present on the surfaces of the porous metallic tissue scaffold-implant, and having ex vivo cultured tissue on the inert biocompatible metal film,
wherein the porous three-dimensional metallic tissue scaffold-implant is effective to receive tissue ingrowth upon implantation in a patient; and
implanting said porous three-dimensional metallic tissue scaffold-implant in a patient.
18. The method of claim 17 , wherein said porous three-dimensional metallic tissue scaffold-implant is shaped and sized as an acelabular cup implant.
19. The method of claim 17 , wherein said porous three-dimensional metallic tissue scaffold has an interconnected porosity for facilitating nutrient diffusion and media circulation throughout the porous three-dimensional metallic tissue scaffold.